
Tourmaline Bio’s Exciting Healthcare Innovations: A Peek into Their Leerink Partners Conference Presentation (2025)
Tourmaline Bio’s CEO, Sandeep Kulkarni, to Speak at Upcoming Investor Conference New York, NY – March 3, 2025 – In an exciting turn of events, Tourmaline Bio, Inc. (TRML), a pioneering biotechnology company focusing on late-stage clinical development of innovative medicines for patients with immune and inflammatory diseases, has announced that its Co-Founder and CEO,…